Table 3.
Impact of a high level of high-density lipoprotein cholesterol on obstructive CAD according to OGC status.
| Variables | OR (95% CI) | P |
|---|---|---|
| OGC group | ||
| Model 1 | 0.584 (0.343–0.995) | 0.048 |
| Model 2 | 0.485 (0.277–0.851) | 0.012 |
| Model 3 | 0.514 (0.290–0.909) | 0.022 |
| Model 4 | 0.525 (0.292–0.943) | 0.031 |
| Non-OGC group | ||
| Model 1 | 0.949 (0.549–1.640) | 0.850 |
| Model 2 | 0.931 (0.526–1.647) | 0.806 |
| Model 3 | 0.903 (0.506–1.612) | 0.731 |
| Model 4 | 0.919 (0.507–1.663) | 0.779 |
BMI body mass index, CAD coronary artery disease, CI confidence interval, HbA1C hemoglobin A1C, OGC optimal glycemic control, OR odds ratio.
Model 1: Unadjusted.
Model 2: Adjusted for age and sex.
Model 3: Adjusted for age, sex, obesity, hypertension, and current smoking.
Model 4: Adjusted for age, sex, obesity, hypertension, current smoking, triglyceride level, low-density lipoprotein cholesterol level, and a family history of CAD.